RONALD ASBURY ANDREWS
CIK 1299153 · Former CEO · last filed 2026-05-18
RONALD ASBURY ANDREWS is a Former CEO who has filed 60 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PSTV, was dated May 18, 2026. Across all open-market trades the lifetime net is +$43.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $349.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$349.1K
7
60
$43.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSTV | Director | — | $5.01 | — | $0 | 1 | 2026-05-18 |
| PRPO | Director | 15,796 | $22.10 | $349.1K | $0 | 18 | 2026-01-20 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Former CEO | 583,212 | $3.20 | $1.87M | $43.07M | 15 | 2022-12-09 |
| Oxford Immunotec Global PLC (OXFD) Delisted | Director | 4,081 | — | — | $0 | 6 | 2020-06-26 |
| LIFE | President, Medical Sciences | 0 | $15.61 | $0 | $154.8K | 7 | 2014-02-04 |
| CLARIENT, INC (CLRT) Delisted | Vice-Chairman and CEO | 0 | — | — | $53.0K | 7 | 2010-12-23 |
| Cardiac Science CORP (CSCX) Delisted | Director | 0 | — | — | $0 | 5 | 2010-12-06 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | PSTV | Grant (A) | — | $0 | EDGAR |
| 2026-01-20 | PRPO | Grant (A) | +568 | $10.0K | EDGAR |
| 2026-01-06 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2025-10-16 | PRPO | Grant (A) | +568 | $10.0K | EDGAR |
| 2025-07-18 | PRPO | Grant (A) | +676 | $10.0K | EDGAR |
| 2025-04-17 | PRPO | Grant (A) | +1,785 | $10.0K | EDGAR |
| 2025-01-16 | PRPO | Grant (A) | +1,639 | $10.0K | EDGAR |
| 2025-01-16 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2024-10-17 | PRPO | Grant (A) | +1,510 | $10.0K | EDGAR |
| 2024-09-06 | PRPO | Mixed | — | $0 | EDGAR |